Indicaton
Hospital- and community-acquired pneumonia
Hospital- and community-acquired pneumonia
Fosmanogepix is a novel-class i.v. and oral antifungal with activity against yeasts and molds.
Staphylococcus aureus bacteremia
Invasive aspergillosis and mucormycosis